MedTrace Logo

Erectae Spinae Block Versus Intrathecal Morphine for Postoperative Analgesis in Lumbar Surgeries

NCT05123092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-06-07

No results posted yet for this study

Summary

The study design will be double blinded retrospective controlled comparative study.

The patients will be included in the study shoud be in the following category:

* American Society of Anesthesiologists (ASA) physical status I, II
* Age range from 18 and 70 years.

The patients will be discarded from the study shoud be in the following:

* patient refusal.
* significant renal, hepatic and cardiovascular diseases.
* Pregnancy.
* Any contraindication to regional anesthesia such as local infection or bleeding disorders.
* Chronic opioid use, history of chronic pain and cognitive disorders.
* Lumbar spine lesion revision and dural tear. Postoperative pain will be evaluated using a visual analogue scale (VAS) score as primary outcome measure.

demographic data ( Age, Weight, sex and height) , ASA classification ,mean operative times (min), time to the first rescue analgesic (min) ,intraoperative fentanyl consumption(microgram),postoperative opioid consumption ,sedation score, hemodynamics intraoperative and postoperative ( BP ,H R and oxgen saturation %) and complications as 2ry outcome measures.

Conditions

  • Post-operative
  • Analgesia

Interventions

OTHER

Ultrasound guided lumbar erectae spinae block

One group by using ultrasound for making erectae spinae block

OTHER

Intrathecal Morphine injection

Injecting intrathecal morphine

Sponsors & Collaborators

  • Fayoum University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05123092 on ClinicalTrials.gov